Claims Involving Cancer Drug Tasigna Sent to MDL in Middle District of Florida



DOCUMENTS
  • Order


WASHINGTON, D.C. –– Finding that centralization of claims involving Novartis’ cancer drug Tasigna was appropriate, the U.S. Judicial Panel on Multidistrict Litigation has established an MDL docket in the Middle District of Florida, according to an order released by the Panel.

In the Aug. 10 order, the JPML assigned the cases to Hon. Roy Bale Dalton, a “jurist who is familiar with the contours of multidistrict litigation.”

The JPML opined that coordinating the actions was appropriate, given that the actions are expected to share factual questions arising from “allegations that Novartis failed to appropriately warn of the risks that use …






UPCOMING CONFERENCES




HarrisMartin’s Webinar Series: MDL Update on Philips CPAP, BiPAP & Ventilator Litigation

October 21, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS



HarrisMartin's New Jersey Asbestos Litigation Conference

February 09, 2022 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS